These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 18559528)

  • 1. Neo-organoid of marrow mesenchymal stromal cells secreting interleukin-12 for breast cancer therapy.
    Eliopoulos N; Francois M; Boivin MN; Martineau D; Galipeau J
    Cancer Res; 2008 Jun; 68(12):4810-8. PubMed ID: 18559528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice.
    Maestroni GJ; Hertens E; Galli P
    Cell Mol Life Sci; 1999 Apr; 55(4):663-7. PubMed ID: 10357234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of MSCs expressing islet neogenesis associated protein (INGAP): INGAP secretion and cell survival
    Petropavlovskaia M; Assouline-Thomas B; Cuerquis J; Zhao J; Violette-Deslauriers S; Nano E; Eliopoulos N; Rosenberg L
    Heliyon; 2024 Aug; 10(15):e35372. PubMed ID: 39170459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A1-reprogrammed mesenchymal stromal cells prime potent antitumoral responses.
    Gonçalves MP; Farah R; Bikorimana JP; Abusarah J; El-Hachem N; Saad W; Talbot S; Stanga D; Beaudoin S; Plouffe S; Rafei M
    iScience; 2024 Mar; 27(3):109248. PubMed ID: 38433914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Mesenchymal Stem Cells in Modulating the Breast Cancer Microenvironment.
    Zhang L
    Cell Transplant; 2023; 32():9636897231220073. PubMed ID: 38135917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composition of Conditioned Media from Radioresistant and Chemoresistant Cancer Cells Reveals miRNA and Other Secretory Factors Implicated in the Development of Resistance.
    Molodtsova D; Guryev DV; Osipov AN
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Mesenchymal Stem Cells and Exosomes in Tumor Development and Targeted Antitumor Therapies.
    Yang E; Jing S; Wang Y; Wang H; Rodriguez R; Wang Z
    Stem Cells Int; 2023; 2023():7059289. PubMed ID: 36824409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast Cancer Therapy: The Potential Role of Mesenchymal Stem Cells in Translational Biomedical Research.
    Gentile P
    Biomedicines; 2022 May; 10(5):. PubMed ID: 35625915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral Immunity to Allogeneic Immunoproteasome-Expressing Mesenchymal Stromal Cells Requires Efferocytosis by Endogenous Phagocytes.
    Bikorimana JP; Abusarah J; Salame N; El-Hachem N; Shammaa R; Rafei M
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice.
    Abusarah J; Khodayarian F; El-Hachem N; Salame N; Olivier M; Balood M; Roversi K; Talbot S; Bikorimana JP; Chen J; Jolicoeur M; Trudeau LE; Kamyabiazar S; Annabi B; Robert F; Pelletier J; El-Kadiry AE; Shammaa R; Rafei M
    Cell Rep Med; 2021 Dec; 2(12):100455. PubMed ID: 35028603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy.
    Hassanzadeh A; Altajer AH; Rahman HS; Saleh MM; Bokov DO; Abdelbasset WK; Marofi F; Zamani M; Yaghoubi Y; Yazdanifar M; Pathak Y; Chartrand MS; Jarahian M
    Front Cell Dev Biol; 2021; 9():686453. PubMed ID: 34322483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells as a double-edged sword in tumor growth: focusing on MSC-derived cytokines.
    Liang W; Chen X; Zhang S; Fang J; Chen M; Xu Y; Chen X
    Cell Mol Biol Lett; 2021 Jan; 26(1):3. PubMed ID: 33472580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically engineered mesenchymal stem cells: targeted delivery of immunomodulatory agents for tumor eradication.
    Mosallaei M; Simonian M; Ehtesham N; Karimzadeh MR; Vatandoost N; Negahdari B; Salehi R
    Cancer Gene Ther; 2020 Dec; 27(12):854-868. PubMed ID: 32418986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in the application of organoids to breast cancer research.
    Yang L; Liu B; Chen H; Gao R; Huang K; Guo Q; Li F; Chen W; He J
    J Cell Mol Med; 2020 May; 24(10):5420-5427. PubMed ID: 32283573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice.
    Stamatopoulos A; Stamatopoulos T; Gamie Z; Kenanidis E; Ribeiro RDC; Rankin KS; Gerrand C; Dalgarno K; Tsiridis E
    J Bone Oncol; 2019 Jun; 16():100231. PubMed ID: 30956944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro biomimetic engineering of a human hematopoietic niche with functional properties.
    Bourgine PE; Klein T; Paczulla AM; Shimizu T; Kunz L; Kokkaliaris KD; Coutu DL; Lengerke C; Skoda R; Schroeder T; Martin I
    Proc Natl Acad Sci U S A; 2018 Jun; 115(25):E5688-E5695. PubMed ID: 29866839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype.
    Hill BS; Pelagalli A; Passaro N; Zannetti A
    Oncotarget; 2017 Sep; 8(42):73296-73311. PubMed ID: 29069870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy.
    Aliperta R; Welzel PB; Bergmann R; Freudenberg U; Berndt N; Feldmann A; Arndt C; Koristka S; Stanzione M; Cartellieri M; Ehninger A; Ehninger G; Werner C; Pietzsch J; Steinbach J; Bornhäuser M; Bachmann MP
    Sci Rep; 2017 Feb; 7():42855. PubMed ID: 28205621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically modified mesenchymal stromal cells in cancer therapy.
    Sage EK; Thakrar RM; Janes SM
    Cytotherapy; 2016 Nov; 18(11):1435-1445. PubMed ID: 27745603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse.
    Nowakowski A; Drela K; Rozycka J; Janowski M; Lukomska B
    Stem Cells Dev; 2016 Oct; 25(20):1513-1531. PubMed ID: 27460260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.